5.942
3.88%
0.222
After Hours:
5.94
-0.002
-0.03%
Precipio Inc Stock (PRPO) Latest News
PRPO (Precipio) 3-Year Book Growth Rate : -14.20% (As of Sep. 2024) - GuruFocus.com
How to Take Advantage of moves in (PRPO) - Stock Traders Daily
PRPO (Precipio) 3-Year EPS without NRI Growth Rate : 28.00% (As of Sep. 2024) - GuruFocus.com
PRPO (Precipio) 3-Year EBITDA Growth Rate : 32.10% (As of Sep. 2024) - GuruFocus.com
PRPO (Precipio) 3-Year Revenue Growth Rate : 16.60% (As of Sep. 2024) - GuruFocus.com
PRPO (Precipio) Future 3-5Y Total Revenue Growth Rate : N/A (As of Nov. 26, 2024) - GuruFocus.com
PRPO (Precipio) Growth Rank : 3 (As of Nov. 25, 2024) - GuruFocus.com
Two Smaller Companies Worthy of Your "Attention" - Yahoo Finance
PRPO (Precipio) 3-Year FCF Growth Rate : 32.40% (As of Sep. 2024) - GuruFocus.com
PRPO (Precipio) GF Value Rank : 2 (As of Nov. 23, 2024) - GuruFocus.com
PRPO (Precipio) Debt-to-Equity : 0.11 (As of Sep. 2024) - GuruFocus.com
Precipio Inc (PRPO) Q3 2024 Earnings Call Highlights: Strong Growth in Diagnostic Services and ... - Yahoo Finance
Earnings call: Precipio nears breakeven with robust Q3 growth By Investing.com - Investing.com Canada
Earnings call: Precipio nears breakeven with robust Q3 growth - Investing.com
Precipio Reports Improved Financials Amid Challenges - TipRanks
(PRPO) On The My Stocks Page - Stock Traders Daily
PRPO (Precipio) Net Issuance of Preferred Stock : $0.00 Mil (TTM As of Jun. 2024) - GuruFocus.com
Insider Sale: Director Richard Sandberg Sells Shares of Precipio Inc (PRPO) - GuruFocus.com
Precipio director Richard Sandberg sells $12,558 in stock - Investing.com
Precipio director Richard Sandberg sells $12,558 in stock By Investing.com - Investing.com UK
Precipio Third Quarter 2024 Earnings: US$0.42 loss per share (vs US$1.04 loss in 3Q 2023) - Yahoo Finance
Precipio (NASDAQ: PRPO) to Host Q3-2024 Shareholder Update Call - Defense World
Precipio to Host Q3-2024 Shareholder Update Call - TipRanks
Precipio Announces Q3-2024 Shareholder Update Call - The Manila Times
Precipio (PRPO) Sets Q3 2024 Earnings Call: Cancer Diagnostics Update Coming Nov 18 | PRPO Stock News - StockTitan
Trend Tracker for (PRPO) - Stock Traders Daily
(PRPO) Trading Report - Stock Traders Daily
Precipio Expands Bloodhound™ MPN Panel by Adding CALR Mutation Subtyping - The Manila Times
PRPO Stock Earnings: Precipio Reported Results for Q2 2024 - MSN
Long Term Trading Analysis for (PRPO) - Stock Traders Daily
Precipio (NASDAQ:PRPO) Shares Pass Above Two Hundred Day Moving Average of $5.85 - Defense World
When the Price of (PRPO) Talks, People Listen - Stock Traders Daily
Precipio Incentivizes Staff with Strategic Stock Option Repricing - TipRanks
Precipio Announces Employee Stock Option Plan Repricing - ForexTV.com
Precipio Announces Stock Option Repricing for Employees - Investing.com
Zacks Initiates Coverage of Precipio With Outperform Recommendation - Yahoo Finance
Objective long/short (PRPO) Report - Stock Traders Daily
Head-To-Head Comparison: Prenetics Global (NASDAQ:PRE) vs. Precipio (NASDAQ:PRPO) - Defense World
Precipio Inc (PRPO) Q2 2024 Earnings Call Transcript Highlights: Revenue Growth and Path to Profitability - GuruFocus.com
Market Might Still Lack Some Conviction On Precipio, Inc. (NASDAQ:PRPO) Even After 29% Share Price Boost - Simply Wall St
Precipio, Inc. (NASDAQ:PRPO) Q2 2024 Earnings Call Transcript - Insider Monkey
Earnings call: Precipio Q2 2024 results show progress towards profitability By Investing.com - Investing.com Canada
Precipio (NASDAQ:PRPO) Stock Price Passes Below 200-Day Moving Average of $5.85 - Defense World
Precipio Second Quarter 2024 Earnings: US$0.83 loss per share (vs US$1.88 loss in 2Q 2023) - Simply Wall St
Precipio Announces Q2-2024 Shareholder Update Call - ForexTV.com
Hematologic Malignancies Testing Markets, 2023-2033: - GlobeNewswire
Financial Survey: Precipio (NASDAQ:PRPO) vs. Prenetics Global (NASDAQ:PRE) - Defense World
(PRPO) Trading Advice - Stock Traders Daily
Precipio Reports $0.3M cash generated by operations (unaudited) in Q2-2024, as the company advances towards breakeven - StockTitan
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):